ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1061

How Does Rheumatoid Arthritis Disease Activity Affect Development of Upper Cervical Lesions? a Retrospective Study of Cervical Spine X-Rays Combined with a Cohort Study in Rheumatoid Arthritis Patients

Osamu Ishida1,2, Katsunori Ikari3, Eisuke Inoue3, Atsuo Taniguchi4, Shigeki Momohara1 and H. Yamanaka3, 1Orthopedics, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Orthopedics, Kyoto City Hospital, Kyoto, Japan, 3Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 4Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Atlanto-axial subluxation, Cervical spine, rheumatoid arthritis (RA) and spine involvement

  • Tweet
  • Email
  • Print
Session Information

Title: Epidemiology and Public Health (ACR): Rheumatoid Arthritis and Systemic Lupus Erythematosus Outcomes

Session Type: Abstract Submissions (ACR)

Background/Purpose It is believed that 40% to 80% of patients with rheumatoid arthritis (RA) have cervical spine lesions. In particular, atlantoaxial subluxation (AAS) and vertical subluxation (VS) are clinically important. However, little is known about how disease activity and other factors are involved in their development.  The aim of this study is to identify risk factors for upper cervical lesions in RA patients.

Methods IORRA is a prospective observational cohort study of Japanese patients with RA established in 2000 at the Institute of Rheumatology, Tokyo Women’s Medical University. Approximately 5,000 patients with RA are involved in each phase of the biannual survey. In our department, when RA patients schedule surgery, dynamic X-rays of the cervical spine are conventionally taken to assess instabilities in case tracheal intubation for general anesthesia is required. In this study, we evaluated these X-rays and investigated their relevance to the integrated data in the IORRA cohort study. Inclusion criteria were: (1) scheduled surgery in our department from 1 April 2010 to 31 March 2013, and (2) registration into the IORRA cohort study within 2 years from onset of RA. Fifty-seven patients were selected, with the following characteristics: women, 49 (85.9%); median onset age, 56 years; disease duration, 8.5 years; and DAS28, 4.3. Cervical X-rays were measured two times by one board-certified orthopedic surgeon and mean values were generally used. To assess AAS, the atlantodental interval (ADI) was measured, and for VS, the Redlund-Johnell method (R-J) was adopted. AAS was defined as ADI≧3mm; VS was defined as 34mm≦R-J in males, 29mm≦R-J in females. For statistical analysis, regression analysis was used for ADI and R-J, and logistic regression analysis was used for AAS and VS.

Results Median ADI was 2.8mm, and R-J was 34mm. Twenty-seven patients had AAS (48.2%) and twelve had VS (21.4%). No significant correlation between ADI and R-J was observed (ρ=-0.025, p=0.8). By univariate regression analysis, gender (p=0.004), height (p<0.0001), body weight (p=0.03), total methotrexate dose (p=0.002), and DAS28 maximum value (p=0.001) and integrated value (p=0.003) during the IORRA enrollment period were significantly relevant to R-J. Multivariate regression analysis revealed height (β=0.59, 95%CI: 0.011-0.25, p<0.0001) and maximum DAS28 (β=-0.27, 95%CI: -2.4- to -0.33, p=0.011) to be significantly associated with R-J. No factors were significantly associated with ADI. By univariate logistic regression analysis, maximum DAS28 (OR=2.4, 95%CI: 1.3-5.2, p=0.01) was significantly associated with VS. Total duration of biological drug use (OR=1.2, 95%CI: 1.0-1.6, p=0.04) was also significantly associated with AAS, but this involved development and was not thought to be causal.

Conclusion Higher RA disease activity appears to be a significant risk factor for VS development and severity, regardless of integrated value of disease activities. We suggest that RA disease activity should be tightly controlled to prevent development of upper cervical lesions, particularly VS.


Disclosure:

O. Ishida,
None;

K. Ikari,

Janssen, Mitsubishi Tanabe Parma, Abbvie Japan,

8;

E. Inoue,
None;

A. Taniguchi,
None;

S. Momohara,

Abbvie Japan, Chugai Parmaceutical, Eisai, Mitsubishi Tanabe Parma, Takeda Parmaceutical,

8;

H. Yamanaka,

Abbott, AbbVie, Asahikasei , Astellas, AstraZeneca, Bristol-Myers Squib, Chugai, Daiichi Sankyo, Eisai, GlaxoSmithKline, Janssen, Mitsubishi Tanabe, MSD, Nippon Kayaku, Pfizer, Santen, Taishotoyama, Takeda, Teijin,

2,

Abbott, AbbVie, Astellas, Bristol-Myers Squib, Chugai, Eisai, Mitsubishi Tanabe, Pfizer, Takeda, Teijin,

8,

Abbott, AbbVie, Astellas, AstraZeneca, Bristol-Myers Squib, Chugai, Daiichi Sankyo, Eisai, Mitsubishi Tanabe, Nippon Kayaku, Pfizer, Takeda, Teijin,

5.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/how-does-rheumatoid-arthritis-disease-activity-affect-development-of-upper-cervical-lesions-a-retrospective-study-of-cervical-spine-x-rays-combined-with-a-cohort-study-in-rheumatoid-arthritis-patient/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology